Top Markets
#1 MowCat MowCat +26.39%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +17.61%
#3 Versatize Coin Versatize Coin +16.67%
#4 Pons Pons +11.66%
#5 OriginTrail OriginTrail +11.36%
#6 QuantixAI QuantixAI +9.67%
#7 Wrapped NXM Wrapped NXM +9.54%
#8 StonkBroker StonkBroker +8.89%
#9 Collector Crypt Collector Crypt +8.37%
#10 Siren Siren +8.12%
Coin of the day
MowCat MowCat
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Great Novel Therapeutics Biotech & Medicals Great Novel Therapeutics Biotech & Medicals

Great Novel Therapeutics Biotech & Medicals

7427
Classifica tra le azioni #20753
Great Novel Therapeutics Biotech & Medicals specializes in crafting... Great Novel Therapeutics Biotech & Medicals specializes in crafting pharmaceutical solutions to combat advanced and treatment-resistant cancers. Their primary focus lies in the realm of cancer immunotherapy, encompassing the creation of compounds such as tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was previously known as GNT Biotech & Medicals Corporation. Established in 2013, its headquarters are situated in Taipei City, Taiwan.
Prezzo delle azioni
$2.33
Capitalizzazione di mercato
$122.59M
Variazione (1 giorno)
0.41%
Variazione (1 anno)
110.45%
Paese
TW
Scambia Great Novel Therapeutics Biotech & Medicals (7427)

Categoria

Healthcare
Ricavi di Great Novel Therapeutics Biotech & Medicals (7427)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Great Novel Therapeutics Biotech & Medicals, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Great Novel Therapeutics Biotech & Medicals da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH